Bank of Nova Scotia trimmed its holdings in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 14.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 347,747 shares of the medical research company’s stock after selling 58,003 shares during […]